Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $129M invested in Invesco Biotechnology & Genome ETF in 2014 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+13
Holders Change %
+21.67%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
25
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Jane Street
New York
|
$4.29M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$4.45M |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$17.5M |
| 4 |
4
HighTower Advisors
Chicago,
Illinois
|
$3.22M |
| 5 |
VKH
5
Virtu KCG Holdings
New York
|
$2.63M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Invesco
Atlanta,
Georgia
| – | -$259K | -7,000 | Closed |
|
|
B
77
Baird
Milwaukee,
Wisconsin
| – | -$210K | -5,661 | Closed |
|
78
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$19K | -500 | Closed |
|
|
HR
79
Howe & Rusling
Rochester,
New York
| – | -$1K | -29 | Closed |
|
|
JG
80
Jefferies Group
New York
| – | -$1K | -28 | Closed |
|